First Trust Direct Indexing’s Bristol-Myers Squibb BMY Stock Holding History

First Trust Direct Indexing’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,428	Closed	-$1.73M	–	117
2024 Q3	$1.73M	Buy	33,428 +11,831	+55%	+$555K	0.09%	228
2024 Q2	$897K	Sell	21,597 -723	-3%	-$32.4K	0.06%	333
2024 Q1	$1.21M	Buy	22,320 +7,649	+52%	+$390K	0.09%	254
2023 Q4	$753K	Sell	14,671 -3,371	-19%	-$177K	0.07%	334
2023 Q3	$1.05M	Sell	18,042 -285	-2%	-$17.5K	0.12%	186
2023 Q2	$1.17M	Buy	18,327 +3,209	+21%	+$215K	0.13%	176
2023 Q1	$1.05M	Sell	15,118 -2,579	-15%	-$182K	0.12%	195
2022 Q4	$1.27M	Sell	17,697 -1,401	-7%	-$106K	0.17%	152
2022 Q3	$1.36M	Buy	19,098 +10	+0.1%	+$725	0.2%	123
2022 Q2	$1.47M	Buy	19,088 +1,894	+11%	+$144K	0.2%	118
2022 Q1	$1.26M	Buy	17,194 +3,204	+23%	+$215K	0.15%	165
2021 Q4	$872K	Sell	13,990 -435	-3%	-$25.5K	0.11%	217
2021 Q3	$854K	Buy	14,425 +588	+4%	+$38.7K	0.12%	210
2021 Q2	$925K	Sell	13,837 -2,176	-14%	-$142K	0.14%	186
2021 Q1	$1.01M	Buy	16,013 +1,323	+9%	+$82.3K	0.27%	92
2020 Q4	$904K	Buy	+14,690	New	+$903K	0.24%	95

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

First Trust Direct Indexing's BMY Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 33,428 shares — an estimated $1.73M sold.

First Trust Direct Indexing first reported a position in BMY in Q4 2020 and held it in 16 quarters. The position peaked at $1.73M in Q3 2024. 2,493 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

First Trust Direct Indexing reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
First Trust Direct Indexing sold 33,428 Bristol-Myers Squibb shares in Q4 2024, an estimated $1.73M.
First Trust Direct Indexing first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 16 quarters.
First Trust Direct Indexing's Bristol-Myers Squibb position peaked at $1.73M in Q3 2024.
2,493 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.